文献速递主动脉外科瓣膜外科

人工主动脉瓣心内膜炎再次主动脉根部置换:主动脉移植物影响

Reoperative aortic root replacement for prosthetic aortic valve endocarditis: impact of aortic graft.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

研究比较既往主动脉瓣置换(AV)与既往主动脉手术(AO)患者因人工瓣膜心内膜炎行再次主动脉根部置换的结局。共纳入2004—2021年2个主动脉中心的130例患者(AO组59例、AV组71例),经逆概率治疗加权匹配。AO组卒中与需透析的肾衰竭发生率更高,住院死亡相近,5年生存与再手术累积发生率两组相当。

要点

  • AO组卒中发生率12.4%高于AV组0.9%,需透析的肾衰竭11.5%高于2.5%。
  • 住院死亡AO组21.5%与AV组18.6%相近。
  • 5年生存AO组68.9%与AV组62.7%相近(P=0.70),再手术累积发生率亦相近。

核心结论

  • 因人工瓣膜/移植物心内膜炎行再次主动脉根部置换属高风险手术。
  • AO组术后并发症发生率高于AV组。
  • 存活度过手术期的患者中,两组5年生存率与再手术率相当。

研究设计与样本

  • 2004—2021年2个主动脉中心的再次主动脉根部置换病例对照研究,共130例(AO组59例、AV组71例)。
  • 按有无主动脉移植物分为既往主动脉手术(AO)组与既往主动脉瓣置换(AV)组,采用逆概率治疗加权匹配。
  • 用Kaplan-Meier法分析远期生存,用Fine and Gray模型比较再手术累积发生率。

主要发现

  • 匹配后AO组卒中发生率为12.4%,AV组为0.9%。
  • 匹配后AO组需透析的肾衰竭发生率为11.5%,AV组为2.5%。
  • 住院死亡率AO组为21.5%,AV组为18.6%。
  • 5年生存率AO组为68.9%(56.6-83.8%),AV组为62.7%(48.1-81.7%),P=0.70。
  • 再手术累积发生率AO组为6.3%(0.0-13.2%),AV组为6.1%(0.0-15.1%),P=0.69。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Existing aortic graft complicates the surgical management of prosthetic valve endocarditis (PVE); yet, its impact has not been well studied. We compared outcomes of patients with prior aortic valve replacement (AVR) versus aortic surgery plus AVR, who underwent reoperative aortic root replacement (ARR) for PVE of the aortic valve. METHODS: All patients who underwent reoperative ARR for PVE between 2004 and 2021 from 2 aortic centres were included. Two groups were formed based on the presence/absence of aortic graft: prior aortic surgery (AO) and prior AVR (AV) alone. Inverse propensity treatment weighting matched the groups. The Kaplan-Meier method was used to analyse long-term survival, and Fine and Gray model was used to compare the cumulative incidence of reoperation. RESULTS: A total of 130 patients were included (AO n = 59; AV n = 71). After matching, AO patients had increased stroke incidence (12.4% vs 0.9%) and renal failure requiring dialysis (11.5% vs 2.5%). In-hospital mortality was comparable (21.5% AO and 18.6% AV). Survival over 5 years was 68.9% (56.6-83.8%) in AO and 62.7% (48.1-81.7%) in AV (P = 0.70). The cumulative incidence of reoperation was similar [AO 6.3% (0.0-13.2%) vs AV 6.1% (0.0-15.1%), P = 0.69]. CONCLUSIONS: Reoperative ARRs for prosthetic valve/graft endocarditis are high-risk procedures. AO patients had higher incidence of postoperative morbidity versus AV patients. For all patients surviving operative intervention, survival and reoperation rates over 5 years were comparable between groups.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Levine D, Patel P, Zhao Y, et al. Reoperative aortic root replacement for prosthetic aortic valve endocarditis: impact of aortic graft. Eur J Cardiothorac Surg. 2023. PMID: 37494468. doi:10.1093/ejcts/ezad268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。